Andrew Technologies, LLC, is a medical technology company incorporated in 2007 with a proprietary surgical innovation called Tissue Liquefaction Technology™ (TLT) which was first patented in 1997. The first product to utilize TLT was launched in 2003 by Alcon as the Aqualase Liquefaction Device® for cataract surgery. In 2012, the FDA cleared HydraSolve® Lipoplasty System, and Andrew Technologies commenced a pilot launch of that device to Plastic Surgery opinion leaders in 2013.
Andrew Technologies’ CEO, Tom Albright, approached Leftcoast Studios to completely redesign the HydraSolve website. The previous HydraSolve website was poorly coded, non-responsive, and very dated looking. Numerous website mockups and wireframe flow charts were created and presented to the board of directors. After the approval of the website mockups had been completed, a new, responsive WordPress theme was developed for the new HydraSolve website.
We have been working with HydraSolve for over 10 years on numerous projects and they have been nothing but pleased with the outcome.